<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-07-07T18:50:46Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/6253" metadataPrefix="marc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/6253</identifier><datestamp>2024-07-25T07:33:04Z</datestamp><setSpec>com_10259_4363</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4365</setSpec><setSpec>com_10259_6256</setSpec><setSpec>com_10259_9476</setSpec><setSpec>com_10259.4_106</setSpec><setSpec>col_10259_9477</setSpec><setSpec>col_10259_4366</setSpec><setSpec>col_10259_6257</setSpec><setSpec>col_10259_4364</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield tag="042" ind1=" " ind2=" ">
<subfield code="a">dc</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Fernández Pampín, Natalia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Vaquero Gutiérrez, Mónica</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Gil Antón, Tania</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Espino Ordóñez, Gustavo</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Fernández Zoppino, Darío</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">García Ruiz, Begoña</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Busto Vázquez, Natalia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="260" ind1=" " ind2=" ">
<subfield code="c">2022-01</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">Three neutral Pt(II) complexes containing 1-Methylimidazole and the antifungal imidazolyl drugs Clotrimazole and Bifonazole have been prepared. The general formula of the new derivatives is [Pt(κ2-(C^N)Cl(L)], where C^N stands for ppy = 2-phenylpyridinate, and L = 1-Methylimidazole (MeIm) for [Pt-MeIm]; L = Clotrimazole (CTZ) for [Pt-CTZ] and L = Bifonazole (BFZ) for [Pt-BFZ]). The complexes have been completely characterized in solution and the crystal structures of [Pt-BFZ] and [Pt-CTZ] have been resolved. Complexes [Pt-MeIm] and [Pt-BFZ] present higher cytotoxicity than cisplatin in SW480 (colon adenocarcinoma), A549 (lung adenocarcinoma) and A2780 (ovarian cancer) cell lines. [Pt-MeIm] shows the highest accumulation in A549 cells, in agreement with its inability to interact with serum albumin. By contrast, [Pt-CTZ] and [Pt-BFZ] interact with serum proteins, a fact that reduces their bioavailability. The strongest interaction with bovine serum albumin (BSA) is found for [Pt-BFZ], which is the least internalized inside the cells. All the complexes are able to covalently interact with DNA. The most cytotoxic complexes, [Pt-MeIm] and [Pt-BFZ] induce cellular accumulation in G0/G1 and apoptosis by a similar pathway, probably involving a reactive oxygen species (ROS) generation mechanism. [Pt-BFZ] turns out to be the most efficient complex regarding ROS generation and causes mitochondrial membrane depolarization, whereas [Pt-MeIm] induces the opposite effect, hyperpolarization of the mitochondrial membrane. On the contrary, the least cytotoxic complex, [Pt-CTZ] cannot block the cell cycle or generate ROS and the mechanism by which it induces apoptosis could be a different one.</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">0162-0134</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">http://hdl.handle.net/10259/6253</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">10.1016/j.jinorgbio.2021.111663</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Cyclometalated platinum(II) complexes</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Clotrimazole</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Bifonazole</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Reactive oxygen species (ROS)</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Antitumoral</subfield>
</datafield>
<datafield tag="245" ind1="0" ind2="0">
<subfield code="a">Distinct mechanism of action for antitumoral neutral cyclometalated Pt(II)-complexes bearing antifungal imidazolyl-based drugs</subfield>
</datafield>
</record></metadata></record></GetRecord></OAI-PMH>